BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  ViewRay Inc. Reports Third Quarter 2017 Financial Results

  Total revenue of $12.2M in Q3 2017, up from $.04M in Q3 2016.

  November 13, 2017

   · 

  21 min read
• Business

  Bruker Announces Quarterly Dividend

  Bruker today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

  November 13, 2017

   · 

  1 min read
• BioCapital

  Gentag’s Pathbreaking IP Now Covers All Key Areas of Wireless Diagnostics Including Diagnostic Skin Patches, Immunoassays and Lab-on-a-Chip Technologies

  Gentag is pleased to announce the issuance of 30 additional patents in Europe covering wireless LOC diagnostic devices.

  November 13, 2017

   · 

  1 min read
• Business

  Medicenna Reports Second Quarter Fiscal 2018 Financial Results

  Medicenna today reported financial results for the three and six months ended September 30, 2017.

  November 13, 2017

   · 

  12 min read
• Business

  RXi Pharma and Gustave Roussy Announce Research Collaboration

  RXi Pharma and Gustave Roussy, a leading Comprehensive Cancer Centre in Europe, today announced that they have entered into a collaborative research agreement to evaluate the potential of RXi’s novel sd-rxRNA technology platform for use in cancer treatments.

  November 13, 2017

   · 

  4 min read
• Genetown

  Rodin Therapeutics Announces Award of Grant Support From The Michael J. Fox Foundation to Advance Novel Treatment Strategy for Parkinson’s Disease

  MJFF is supporting Rodin’s work through two rounds of grant funding, totaling approximately $600,000.

  November 13, 2017

   · 

  3 min read
• Business

  SCIEX Announces Joint Venture With Zhenjang Dian Diagnostics in China

  The parties plan to jointly establish a joint venture in Hangzhou, China to develop, register, manufacture, and commercialize Class I, II and III in vitro diagnostic reagents for the SCIEX Triple Quad™ 4500MD LC-MS/MS system.

  November 13, 2017

   · 

  3 min read
• Drug Development

  RiboQuark Pharmaceutical Technology Co., Ltd., Announces Enrollment of The First Ever Patient in China for a Pivotal Clinical Trial with a siRNA Drug Candidate as Part of a Global Clinical Study of the Ocular Neuroprotectant QPI-1007

  The QRK207 study will determine the effect of QPI-1007 on visual function in subjects with acute non-arteritic ischemic optic neuropathy (NAION).

  November 13, 2017

   · 

  6 min read
• Oragenics Regains Compliance With NYSE American Continued Listing Standards

  In a letter dated November 10, 2017, the Exchange notified the Company that it had successfully regained compliance with the NYSE American continued listing standards.

  November 13, 2017

   · 

  3 min read
• Genetown

  Alnylam Pharmaceuticals Announces Proposed Public Offering of $675M of Common Stock

  All of the shares in the offering are to be sold by Alnylam.

  November 13, 2017

   · 

  5 min read